Found: 35
Select item for more details and to access through your institution.
Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 11, p. 2535, doi. 10.3390/pharmaceutics15112535
- By:
- Publication type:
- Article
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 11, p. 1387, doi. 10.1007/s11912-022-01299-9
- By:
- Publication type:
- Article
Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 9, p. 1, doi. 10.1007/s00520-024-08776-w
- By:
- Publication type:
- Article
Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2013, v. 5, n. 1, p. 1, doi. 10.4084/MJHID.2013.018
- By:
- Publication type:
- Article
The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. 1219, doi. 10.1111/bjh.17989
- By:
- Publication type:
- Article
The wider perspective: twenty years of clinical trials in myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 329, doi. 10.1111/bjh.17892
- By:
- Publication type:
- Article
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
- By:
- Publication type:
- Article
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 4, p. 553, doi. 10.1111/j.1365-2125.2011.04116.x
- By:
- Publication type:
- Article
Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143456
- By:
- Publication type:
- Article
Maturation State-Specific Alternative Splicing in FLT3 -ITD and NPM1 Mutated AML.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3929, doi. 10.3390/cancers13163929
- By:
- Publication type:
- Article
Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 5, p. 606, doi. 10.1111/ejh.14271
- By:
- Publication type:
- Article
BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 6, p. 938, doi. 10.1111/ejh.14107
- By:
- Publication type:
- Article
A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 90, doi. 10.1111/ejh.13775
- By:
- Publication type:
- Article
TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study).
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 364, doi. 10.1111/ejh.13674
- By:
- Publication type:
- Article
Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 343, doi. 10.1111/ejh.13672
- By:
- Publication type:
- Article
Food‐effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 148, doi. 10.1111/ejh.13418
- By:
- Publication type:
- Article
Patient satisfaction with information on oral anticancer agent use.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 1, p. 219, doi. 10.1002/cam4.1239
- By:
- Publication type:
- Article
MRD Tailored Therapy in AML: What We Have Learned So Far.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.603636
- By:
- Publication type:
- Article
Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 5, p. 491, doi. 10.1111/ejh.13315
- By:
- Publication type:
- Article
Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 643, doi. 10.1111/ejh.13155
- By:
- Publication type:
- Article
Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 4, p. 367, doi. 10.1111/ejh.13023
- By:
- Publication type:
- Article
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 3, p. 206, doi. 10.1111/j.1600-0609.2012.01811.x
- By:
- Publication type:
- Article
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 6, p. 467, doi. 10.1111/j.1600-0609.2008.01141.x
- By:
- Publication type:
- Article
A novel mutation in a Turkish patient with Hermansky–Pudlak syndrome type 5.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 4, p. 356, doi. 10.1111/j.1600-0609.2007.01024.x
- By:
- Publication type:
- Article
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 9, p. 1213, doi. 10.1007/s00228-020-02910-3
- By:
- Publication type:
- Article
Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 825, doi. 10.1007/s00228-019-02640-1
- By:
- Publication type:
- Article
Phosphotyrosine-Based Phosphoproteomics of a Panel AML Cell Lines Reveals Oncogenic Signaling and Hyperactive Tyrosine Kinases as Targets for Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S2, doi. 10.1016/j.clml.2017.09.026
- By:
- Publication type:
- Article
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 1, p. 38, doi. 10.1093/cid/ciad141
- By:
- Publication type:
- Article
A Systematic Review of the Evidence of Hematopoietic Stem Cell Differentiation to Fibroblasts.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3063, doi. 10.3390/biomedicines10123063
- By:
- Publication type:
- Article
Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 6, p. 891, doi. 10.1080/0284186X.2019.1585944
- By:
- Publication type:
- Article
Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-247
- By:
- Publication type:
- Article
Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-247
- By:
- Publication type:
- Article
Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article